Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors

Por Kamath, Geetanjali R., Taioli, Emanuela, N. Egorova, Natalia, Llovet, Josep M., Perumalswami, Ponni V., Weiss, Jeffrey J., Schwartz, Myron, Ewala, Stanley, Bickell, Nina A.
Publicado no Front Oncol (2018)

Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus

Por Chekuri, Sweta, Nickerson, Jillian, Bichoupan, Kian, Sefcik, Roberta, Doobay, Kamini, Chang, Sanders, DelBello, David, Harty, Alyson, Dieterich, Douglas T., Perumalswami, Ponni V., Branch, Andrea D.
Publicado no PLoS One (2016)

A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants

Por Shankar, Hari, Blanas, Demetri, Bichoupan, Kian, Ndiaye, Daouda, Carmody, Ellie, Martel-Laferriere, Valerie, Culpepper-Morgan, Joan, Dieterich, Dougles T., Branch, Andrea D., Bekele, Mulusew, Nichols, Kim, Perumalswami, Ponni V.
Publicado no Clin Infect Dis (2016)

Diabetes Mellitus and Advanced Liver Fibrosis Are Risk Factors for Severe Anemia During Telaprevir-based Triple Therapy

Por Crismale, James F., Martel-Laferrière, Valérie, Bichoupan, Kian, Schonfeld, Emily, Pappas, Alexis, Wyatt, Christina, Odin, Joseph A., Liu, Lawrence U., Schiano, Thomas D., Perumalswami, Ponni V., Bansal, Meena, Dieterich, Douglas T., Branch, Andrea D.
Publicado em 2013

Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV

Por Del Bello, David, Cha, Agnes, Sorbera, Maria, Bichoupan, Kian, Levine, Calley, Doyle, Erin, Harty, Alyson, Patel, Neal, Ng, Michel, Gardenier, Donald, Odin, Joseph, Schiano, Thomas D., Fierer, Daniel S., Berkowitz, Leonard, Perumalswami, Ponni V., Dieterich, Douglas T., Branch, Andrea D.
Publicado no Clin Infect Dis (2016)

Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response

Por Bichoupan, Kian, Martel-Laferriere, Valerie, Sachs, David, Ng, Michel, Schonfeld, Emily A., Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Perumalswami, Ponni V., Schiano, Thomas D., Odin, Joseph A., Liu, Lawrence, Moskowitz, Alan J., Dieterich, Douglas T., Branch, Andrea D.
Publicado em 2014

Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection

Por Bichoupan, Kian, Tandon, Neeta, Martel-Laferriere, Valerie, Patel, Neal M, Sachs, David, Ng, Michel, Schonfeld, Emily A, Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Olson, William, Perumalswami, Ponni V, Schiano, Thomas D, Odin, Joseph A, Liu, Lawrence U, Dieterich, Douglas T, Branch, Andrea D
Publicado no World J Hepatol (2017)

Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results

Por Bichoupan, Kian, Tandon, Neeta, Crismale, James F, Hartman, Joshua, Del Bello, David, Patel, Neal, Chekuri, Sweta, Harty, Alyson, Ng, Michel, Sigel, Keith M, Bansal, Meena B, Grewal, Priya, Chang, Charissa Y, Leong, Jennifer, Im, Gene Y, Liu, Lawrence U, Odin, Joseph A, Bach, Nancy, Friedman, Scott L, Schiano, Thomas D, Perumalswami, Ponni V, Dieterich, Douglas T, Branch, Andrea D
Publicado no World J Virol (2017)